65 and older, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change From Baseline to Month 4 for Minutes of Moderate to Vigorous Intensity PA Per WeekPrimary· Baseline, Month 4 (Follow-up)
Minutes of moderate to vigorous intensity physical activity (MVPA) per week measured via accelerometer
Group
Value
95% CI
OA-PCP
0.78
-1.6 – 3.2
Change From Baseline to Month 4 for Steps Per DaySecondary· Baseline, Month 4 (Follow-up)
Step counts were measured via an accelerometer device.
Group
Value
95% CI
OA-PCP
143.7
-174.9 – 462.2
Change From Baseline to Month 4 for Minutes of Sedentary ActivitySecondary· Baseline, Month 4 (Follow-up)
Minutes of sedentary activity were measured via an accelerometer device.
Group
Value
95% CI
OA-PCP
-0.15
-17.0 – 16.7
Change From Baseline to Month 4 in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Function SubscaleSecondary· Baseline, Month 4 (Follow-up)
The Western Ontario and McMasters Universities Osteoarthritis (WOMAC) function subscale includes 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty), with ranges of 0-68 for the function subscale with higher scores indicating worse symptoms and function.
Group
Value
95% CI
OA-PCP
-6.1
-8.7 – -3.4
Change From Baseline to Month 4 in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Pain SubscaleSecondary· Baseline, Month 4 (Follow-up)
The Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Pain Subscale is a measure of lower extremity pain. It includes 5 items rated on a Likert scale of 0 (no pain) to 4 (extreme pain), with a total range of 0-20 with higher scores indicating worse symptoms and function.
Group
Value
95% CI
OA-PCP
-1.9
-2.7 – -1.0
Sponsor's own description
This is a multi-phase study that will develop and test an osteoarthritis (OA) primary care Physical activity Care Pathway (OA-PCP), a scalable intervention that includes: 1) a practical process for physical inactivity screening in primary care, 2) a brief, tailored physical activity (PA) counseling intervention via telephone, 3) connection of patients with community programs and other resources to support PA, and 4) follow-up with patients to deliver additional appropriate counseling and referrals to PA resources.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 25 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03780400.